Literature DB >> 21649576

Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development.

Marco Falasca.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21649576     DOI: 10.2174/092986711796011210

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


× No keyword cloud information.
  3 in total

1.  Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.

Authors:  Charlotte E Edling; Federico Selvaggi; Ragheda Ghonaim; Tania Maffucci; Marco Falasca
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

Review 2.  Autophagy in airway diseases: a new frontier in human asthma?

Authors:  A A Zeki; B Yeganeh; N J Kenyon; M Post; S Ghavami
Journal:  Allergy       Date:  2015-10-20       Impact factor: 13.146

Review 3.  Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts.

Authors:  Marco Falasca; Tania Maffucci
Journal:  Front Physiol       Date:  2014-10-15       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.